The Neuro Experience

The FDA Just Removed a 22-Year-Old Warning | ft. Dr. Mary Claire Haver

Nov 18, 2025
Guest
Mary Claire Haver
Dr. Mary Claire Haver, a renowned OB/GYN and menopause specialist, challenges common misconceptions about menopause. She discusses the FDA's recent removal of the black box warning on hormone therapy, which aims to reduce fear and encourage use. Dr. Haver also tackles the importance of lifestyle changes, such as strength training and sleep, over trendy biohacks. She reveals insights on mental health during menopause and the significance of informed care, emphasizing that menopause is not a disease, but a natural transition.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Black Box Removal Will Reduce Fear

  • The FDA removed the 22-year black box warning on hormone therapy, which should reduce fear and improve uptake.
  • Mary Claire Haver expects this will restore patient-clinician conversations and increase appropriate use of HRT.
INSIGHT

HRT Use Remains Extremely Low

  • Only about 4% of women use FDA-approved HRT, rising to ~7–8% when including compounded products.
  • Low uptake reflects fear, lack of clinician training, and lingering WHI influence.
INSIGHT

Training Shapes Clinician Bias

  • Menopause care is inconsistently taught in OBGYN training and often treated as an afterthought.
  • Clinicians' approach to HRT depends heavily on when they trained, causing wide practice variation.
Get the Snipd Podcast app to discover more snips from this episode
Get the app